CA2739159A1 - Methods for detection and diagnosis of a bone or cartilage disorder - Google Patents

Methods for detection and diagnosis of a bone or cartilage disorder Download PDF

Info

Publication number
CA2739159A1
CA2739159A1 CA2739159A CA2739159A CA2739159A1 CA 2739159 A1 CA2739159 A1 CA 2739159A1 CA 2739159 A CA2739159 A CA 2739159A CA 2739159 A CA2739159 A CA 2739159A CA 2739159 A1 CA2739159 A1 CA 2739159A1
Authority
CA
Canada
Prior art keywords
seq
antibody
nos
polypeptide
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2739159A
Other languages
English (en)
French (fr)
Inventor
Wolfgang Woloszczuk
Gerhard Hawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomarker Design Forschungs GmbH
Original Assignee
Biomarker Design Forschungs GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomarker Design Forschungs GmbH filed Critical Biomarker Design Forschungs GmbH
Publication of CA2739159A1 publication Critical patent/CA2739159A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA2739159A 2008-10-22 2009-10-22 Methods for detection and diagnosis of a bone or cartilage disorder Abandoned CA2739159A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10756408P 2008-10-22 2008-10-22
US61/107,564 2008-10-22
PCT/EP2009/063909 WO2010046443A2 (en) 2008-10-22 2009-10-22 Methods for detection and diagnosis of a bone or cartilage disorder

Publications (1)

Publication Number Publication Date
CA2739159A1 true CA2739159A1 (en) 2010-04-29

Family

ID=41403094

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2739159A Abandoned CA2739159A1 (en) 2008-10-22 2009-10-22 Methods for detection and diagnosis of a bone or cartilage disorder

Country Status (6)

Country Link
US (1) US20110189694A1 (enExample)
EP (1) EP2359145A2 (enExample)
JP (1) JP2012506551A (enExample)
CN (1) CN102203617A (enExample)
CA (1) CA2739159A1 (enExample)
WO (1) WO2010046443A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9404932B2 (en) * 2007-11-05 2016-08-02 Nordic Bioscience A/S Pathology biomarker assay
GB201107922D0 (en) * 2011-05-12 2011-06-22 Nordic Bioscience As Biochemical markers for CVD risk assessment
JP5873652B2 (ja) * 2011-05-31 2016-03-01 国立大学法人京都大学 軟骨疾患治療薬のスクリーニング方法および軟骨疾患治療用改変軟骨細胞
CA2912266A1 (en) * 2013-05-14 2014-11-20 Lisbet HAGLUND Chondroadherin fragments as indicators of intervertebral disc degeneration
JP6420074B2 (ja) 2013-06-27 2018-11-07 国立大学法人京都大学 プテロシン誘導体を含む軟骨欠損、軟骨変性、および／または軟骨菲薄疾患治療剤
CN109748953B (zh) * 2013-08-05 2022-09-02 伊玛提克斯生物技术有限公司 用于治疗多种肿瘤(例如包括nsclc在内的肺癌)的新型免疫疗法
EP3233919B1 (en) * 2014-12-19 2020-11-25 Val-Chum, Limited Partnership Dicam-specific antibodies and uses thereof
WO2016127035A1 (en) * 2015-02-05 2016-08-11 Duke University Methods of detecting osteoarthritis and predicting progression thereof
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
PH12021550850A1 (en) 2015-03-27 2022-10-03 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against various tumors
EP3223017A1 (en) * 2016-03-25 2017-09-27 Université de Liège Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof
CN106117357B (zh) * 2016-06-29 2019-08-30 烟台正海生物科技股份有限公司 Bmp-2抗体及其在检测骨修复材料中bmp-2蛋白含量中的应用
US10646540B2 (en) * 2016-11-18 2020-05-12 City Of Hope Peptide inhibitors of twist
CN107383176A (zh) * 2017-05-10 2017-11-24 于学杰 用于对汉滩病毒和汉城病毒引起的肾综合征出血热分型的多肽
AT521641B1 (de) * 2018-09-12 2020-07-15 Fianostics Gmbh Verfahren zur Diagnose von Lebererkrankungen
WO2021243136A2 (en) * 2020-05-29 2021-12-02 New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery Methods and compositions for treating, preventing the onset and/or slowing progression of osteoarthritis
CN118126974B (zh) * 2024-03-14 2025-04-11 江苏大学附属医院 骨关节炎标记物loxl1及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857456A (en) * 1985-04-30 1989-08-15 The Regents Of The University Of California Assay of Bone morphogenetic protein (BMP) and anti-BMP antibody for the diagnosis of bone disorders
AU2002247004A1 (en) * 2001-01-19 2002-07-30 Cambridge Scientific, Inc. Methods of diagnosis and treatment of osteoporosis
AU2003296953A1 (en) * 2002-12-12 2004-07-09 Strategic Diagnostics Inc. Compositions and methods for detecting animal by product in feed
US8012950B2 (en) * 2003-08-29 2011-09-06 Wisconsin Alumni Research Foundation Method to diagnose and treat degenerative joint disease
US20090075921A1 (en) * 2004-08-04 2009-03-19 Riken Bone/joint disease sensitivity gene and use thereof
GB0510511D0 (en) * 2005-05-23 2005-06-29 St Georges Entpr Ltd Diagnosis of tuberculosis
WO2007045661A1 (en) * 2005-10-20 2007-04-26 Nordic Bioscience Diagnostics A/S Detection or quantification of aggrecan and its fragments
EP2118135A1 (en) * 2006-10-16 2009-11-18 Bayer Schering Pharma AG Crtac as a biomarker, therapeutic and diagnostic target
WO2008134054A1 (en) * 2007-04-26 2008-11-06 Genera Doo Blood biomarkers for bone fracture and cartilage injury

Also Published As

Publication number Publication date
JP2012506551A (ja) 2012-03-15
CN102203617A (zh) 2011-09-28
EP2359145A2 (en) 2011-08-24
WO2010046443A3 (en) 2010-08-12
US20110189694A1 (en) 2011-08-04
WO2010046443A2 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
US20110189694A1 (en) Methods for detection and diagnosis of a bone or cartilage disorder
US20130203088A1 (en) Methods and means for diagnosing spondylarthritis using autoantibody markers
RU2203497C2 (ru) Способ диагностики метаболических костных заболеваний
US8981066B2 (en) Epigenetic mechanisms related to DNA damage and aging
US20110045495A1 (en) Composition and method for diagnosis or detection of renal cancer
CA2814023C (en) Moesin fragments and uses thereof
US20120237948A1 (en) Collagen neoepitope antibody
US20160123993A1 (en) Collagen Type X Alpha-1 Assay
US20090280108A1 (en) Serum amyloid a protein in inflammation and obesity
US20080004232A1 (en) Characterization of c19orf10, a Novel Synovial Protein
US20110124009A1 (en) Composition, kit and method for assaying neuropathy
US20120231477A1 (en) Blood Biomarkers for Bone Fracture and Cartilage Injury
US20220365082A1 (en) Method and means for diagnosis of spondyloarthritis
JP2010085375A (ja) 細胞増殖を伴う糖尿病合併症の検査のための方法、組成物およびキット
US20220196680A1 (en) Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof
JPWO2010074123A1 (ja) ケラタン硫酸の測定方法および測定用キット、これらを用いる関節疾患の検知方法等
WO2018024732A1 (en) Diagnosis and therapy of ankylosing spondylitis
US20100233737A1 (en) Marker specific to an oxidative degradation of tissues containing type iii collagen, means and methods and kits for the diagnosis, monitoring or prognosis of pathologies targeted by this marker

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20151022